Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. (LH) Depreciation & Amortization
The d&a for Labcorp Holdings Inc. (LH) is $681.10 Million with a year-over-year change of +5.84%. Depreciation and Amortization (D&A) is a non-cash expense that allocates the cost of tangible and intangible assets over their useful lives.
LH D&A Chart
LH D&A
$681.10M+354.67% 20Y
Zoom
Current D&A
$681.10M
$681.10 Million
Year-over-Year Change
+5.84%
vs. $643.50M prior year
Historical Data
30
Years of data available
Annual D&A History
| Year | D&A | YoY Change | % Change |
|---|---|---|---|
| 2025 | $681.10M | +$37.60M | +5.84% |
| 2024 | $643.50M | +$66.20M | +11.47% |
| 2023 | $577.30M | +$40.10M | +7.46% |
| 2022 | $537.20M | $-39.80M | -6.90% |
| 2021 | $577.00M | $-248.00M | -30.06% |
| 2020 | $825.00M | +$53.70M | +6.96% |
| 2019 | $771.30M | +$219.20M | +39.70% |
| 2018 | $552.10M | +$18.90M | +3.54% |
| 2017 | $533.20M | +$42.60M | +8.68% |
| 2016 | $490.60M | +$32.80M | +7.16% |
| 2015 | $457.80M | +$212.30M | +86.48% |
| 2014 | $245.50M | +$163.80M | +200.49% |
| 2013 | $81.70M | $-4.60M | -5.33% |
| 2012 | $86.30M | +$500,000 | +0.58% |
| 2011 | $85.80M | +$13.10M | +18.02% |
| 2010 | $72.70M | +$10.10M | +16.13% |
| 2009 | $62.60M | +$4.70M | +8.12% |
| 2008 | $57.90M | $-104.90M | -64.43% |
| 2007 | $162.80M | +$7.80M | +5.03% |
| 2006 | $155.00M | +$5.20M | +3.47% |
| 2005 | $149.80M | +$11.00M | +7.93% |
| 2004 | $138.80M | +$3.20M | +2.36% |
| 2003 | $135.60M | +$33.80M | +33.20% |
| 2002 | $101.80M | $-2.20M | -2.12% |
| 2001 | $104.00M | +$14.40M | +16.07% |
| 2000 | $89.60M | +$5.10M | +6.04% |
| 1999 | $84.50M | +$300,000 | +0.36% |
| 1998 | $84.20M | $-2.60M | -3.00% |
| 1997 | $86.80M | +$2.30M | +2.72% |
| 1996 | $84.50M | — | — |
Related Metrics
Data as of Sunday, June 14, 2026
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter